EUVIMEDEUVIMED entdecken
Crossref

Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease

Jack Price

Murdoch University Research Portal · 01.01.2025

DOI: 10.60867/00000078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Murdoch University Research Portal, erschienen am 01.01.2025. Verfasst von Jack Price.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s Disease (PD) is a progressive, neurodegenerative condition that is increasing in prevalence globally. PD is marked by a loss of dopaminergic neurons in the brain, but system-wide metabolic disturbances are now understood to contribute to disease aetiogenesis. Importantly, whilst the clinical presentation of PD is highly heterogenous, a metabolic basis for stratification into different subtypes is lacking. As such, readily accessible biomarkers of PD that can give insight into disease status are highly sought after to address shortcomings in existing approaches that result in poor diagnostic accuracy, minimal treatment options, and a limited understanding of the disease process.

Schlagwörter

Parkinson's diseaselipid remodelinglipidomicsbiomarkersmetabolic disordersdopaminergic neuronsdisease stratificationneurodegeneration

Zitieren

APA

Price, J. (2025). Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease. Murdoch University Research Portal. https://doi.org/10.60867/00000078

Vancouver

Price J. Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease. Murdoch University Research Portal. 2025. doi:10.60867/00000078

BibTeX
@article{Price2025,
  author = {Price, Jack},
  title = {Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease},
  journal = {Murdoch University Research Portal},
  year = {2025},
  doi = {10.60867/00000078}
}
Kostenlos starten →